Business Medical Dialogues
    • facebook
    • twitter
    Sign in Signup
    • facebook
    • twitter
    Sign in Signup
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    Sign InRegister
    Business Medical Dialogues
    Sign inRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • shares

    Tag: shares

    You Searched For "shares"
    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Farhat Nasim25 Nov 2019 6:30 AM GMT
    The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the sec...
    Zydus Wellness to sell shares worth Rs 2575 crore to Cadilla and three others

    Zydus Wellness to sell shares worth Rs 2575 crore to Cadilla and three others

    Medical Dialogues Bureau29 Jan 2019 3:50 AM GMT
    In a tweet Friday, the Competition Commission of India (CCI) said it 'approves the acquisition of shares in Zydus Wellness Limited by True North...
    Fortis arm sells 15 lakh shares in RHT to Fortis Healthcare International Ltd

    Fortis arm sells 15 lakh shares in RHT to Fortis Healthcare International Ltd

    Ruby Khatun Khatun9 Sep 2018 4:45 AM GMT
    New Delhi: Fortis Healthcare said that its step-down subsidiary RHT Health Trust Manager has sold 15 lakh shares in RHT Health Trust to Fortis...
    Natco Pharma raises Rs 915 crore via QIP

    Natco Pharma raises Rs 915 crore via QIP

    Ruby Khatun Khatun15 Dec 2017 5:06 AM GMT
    New Delhi: Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors (QIP), according to a regulatory...
    Sage shares surge as depression drug succeeds in mid-stage trial

    Sage shares surge as depression drug succeeds in mid-stage trial

    Ruby Khatun Khatun9 Dec 2017 4:00 AM GMT
    Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the...
    Eris, Strides Shasun shares gain up to 7 percent on Rs 500 crore deal

    Eris, Strides Shasun shares gain up to 7 percent on Rs 500 crore deal

    Ruby Khatun Khatun22 Nov 2017 5:15 AM GMT
    New Delhi: Shares of Eris Lifesciences and Strides Shasun rose by as much as 7 percent after both the companies entered into a definitive pact to buy...
    Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit

    Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit

    Ruby Khatun Khatun22 Nov 2017 4:30 AM GMT
    ZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
    Mallinckrodt dives as sales of main drug Acthar disappoint

    Mallinckrodt dives as sales of main drug Acthar disappoint

    Ruby Khatun Khatun9 Nov 2017 4:07 AM GMT
    Shares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and ...
    DBV Technologies peanut allergy drug fails key study

    DBV Technologies peanut allergy drug fails key study

    Ruby Khatun Khatun23 Oct 2017 3:45 AM GMT
    DBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study, sending its...
    Dr Reddys receives EIR for Srikakulam plant, shares soar

    Dr Reddys receives EIR for Srikakulam plant, shares soar

    Ruby Khatun Khatun22 Sep 2017 4:59 AM GMT
    New Delhi: Shares of Dr Reddy's Laboratories Ltd soared by 7.5% after the company said it has received establishment inspection report (EIR) from the ...
    Indoco Remedies Q4 net profit down 14 pc at Rs 18 crore

    Indoco Remedies Q4 net profit down 14 pc at Rs 18 crore

    Ruby Khatun Khatun28 May 2017 3:57 AM GMT
    Drug firm Indoco Remedies reported a 14.36 per cent decline in standalone net profit at Rs 17.94 crore for the March quarter.The company had posted a...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 29 March 2022 11:15 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X